NKTR Nektar Therapeutics : Bullish and Bearish Analyst Opinions
Sentiment & Price
▼
Sentiment Gauge
0
Bull
0
Bear
0
Watch
Bull 50%
Bear 50%
Price & Sentiment
Loading chart...
Recent News
Top Views ▼
No recent news for NKTR
No theses available
Feed
18:24
Mar 31
Mar 31
The tweet expresses a bullish sentiment toward Nektar Therapeutics by urging investors to pay attention.
18:13
Mar 28
Mar 28
The tweet highlights alarming safety concerns regarding rapid cancer development linked to OX40-induced treatments.
17:27
Mar 28
Mar 28
The tweet provides a link to a discussion regarding the OX40 situation for NKTR without expressing a specific market bias.
17:27
Mar 28
Mar 28
The tweet suggests potential clinical trial failures for Sanofi and Nektar Therapeutics, signaling a negative outlook for both companies.
16:30
Mar 28
Mar 28
The author highlights safety concerns regarding Sanofi's amlitelimab and questions Nektar Therapeutics' valuation in light of these developments.
18:29
Mar 15
Mar 15
The author provides a routine portfolio update detailing additions, reductions, and closures across various biotech stocks.
20:21
Mar 12
Mar 12
Nektar Therapeutics is expected to see positive momentum for its alopecia areata treatment following upcoming data presentations and maintenance updates.
About NKTR Analyst Coverage
Buzzberg tracks NKTR (Nektar Therapeutics) across 2 sources. 4 bullish vs 3 bearish calls from 2 analysts. Sentiment: predominantly bullish (11%). 9 total trade ideas tracked.